The process defines the product: what really matters in biosimilar design and production?

por Vulto, Arnold G., Jaquez, Orlando A.
Publicado 2017

Glycosylation profile and biological activity of Remicade® compared with Flixabi® and Remsima®

por Lee, Changsoo, Jeong, Min, Lee, JongAh Joanne, Seo, Saebom, Cho, Sung Chun, Zhang, Wei, Jaquez, Orlando
Publicado 2017

Physicochemical and biological characterization of SB2, a biosimilar of Remicade® (infliximab)

por Hong, Juyong, Lee, Yuhwa, Lee, Changsoo, Eo, Suhyeon, Kim, Soyeon, Lee, Nayoung, Park, Jongmin, Park, Seungkyu, Seo, Donghyuck, Jeong, Min, Lee, Youngji, Yeon, Soojeong, Bou-Assaf, George, Sosic, Zoran, Zhang, Wei, Jaquez, Orlando
Publicado 2016